Bumper Offer - Urjas oil Just @ Rs. 1
Monila Plus is an allopathic medicine The correct dosage of Monila Plus depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Monila Plus is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Monila Plus is used -
Severe
Moderate
Mild
Is the use of Monila Plus safe for pregnant women?
Monila Plus is safe to take during pregnancy.
Is the use of Monila Plus safe during breastfeeding?
Monila Plus does not show any harmful effects in lactating women.
What is the effect of Monila Plus on the Kidneys?
Using Monila Plus does not have any harmful effects on kidneys.
What is the effect of Monila Plus on the Liver?
Monila Plus is not harmful for the liver.
What is the effect of Monila Plus on the Heart?
There are no any side effects of Monila Plus for the heart.
Monila Plus should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Monila Plus unless your doctor advises you to do so -
Is this Monila Plus habit forming or addictive?
Forming a habit of Monila Plus has not been reported.
Interaction between Food and Monila Plus
Taking Monila Plus with food does not harm your health.
Interaction between Alcohol and Monila Plus
Taking Monila Plus with alcohol has not been seen to have harmful effects. However, please be careful if you do so.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Qvar® Redihaler™ (beclomethasone dipropionate HFA)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-356
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; QVAR® (beclomethasone dipropionate HFA)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 763,792